Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11996532 | 0.71 | MCL1 (0.43) | MCL1FAAHHDAC4HDAC1HDAC6 | |
| SCHEMBL1515360 | 0.68 | HPGD (0.46) | MCL1FAAHHDAC1HDAC6 | |
| SCHEMBL10293977 | 0.68 | — | — | |
| SCHEMBL21516603 | 0.66 | PIK3CD (0.48) | MCL1FAAHHDAC1HDAC6 | |
| SCHEMBL23505924 | 0.65 | MCL1 (0.41) | MCL1FAAH | |
| SCHEMBL20290710 | 0.65 | MCL1 (0.41) | MCL1FAAH | |
| SCHEMBL12464050 | 0.65 | MCL1 (0.41) | MCL1FAAHHDAC4HDAC1HDAC6 | |
| SCHEMBL22900019 | 0.65 | MCL1 (0.41) | MCL1FAAH | |
| SCHEMBL1515359 | 0.65 | MCL1 (0.41) | MCL1FAAH | |
| SCHEMBL22951039 | 0.64 | MCL1 (0.38) | MCL1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7976824-B2 | Production of 2-18F-2-deoxy-D-glucose via solid-phase synthesis | GE HEALTHCARE LIMITED (GB) | 2011-07-12 | — | — | US | disclosed |
| US-20070274911-A1 | Production of 2-18F-2-Deoxy-D-Glucose Via Solid-Phase Synthesis | GE HEALTHCARE LIMITED (GB) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070274911-A1 | Production of 2-18F-2-Deoxy-D-Glucose Via Solid-Phase Synthesis | SLC2A1, SLC2A4, SLC2A2 | MCL1 2637/4885FAAH 4050/4885HDAC4 2754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.